{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:36:12Z","timestamp":1793140572946,"version":"4.5.0"},"reference-count":181,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1038\/s41582-026-01183-1","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T10:08:13Z","timestamp":1770718093000},"page":"239-250","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Bridging global diversity gaps in Parkinson disease research"],"prefix":"10.1038","volume":"22","author":[{"given":"Daniel","family":"Teixeira-dos-Santos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2979-3839","authenticated-orcid":false,"given":"Ai-Huey","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2975-8803","authenticated-orcid":false,"given":"Njideka","family":"Okubadejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9384-1305","authenticated-orcid":false,"given":"Lorraine V.","family":"Kalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8722-0908","authenticated-orcid":false,"given":"Artur F. S.","family":"Schuh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,10]]},"reference":[{"key":"1183_CR1","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s10072-011-0816-9","volume":"33","author":"F Raudino","year":"2012","unstructured":"Raudino, F. The Parkinson disease before James Parkinson. Neurol. Sci. 33, 945\u2013948 (2012).","journal-title":"Neurol. Sci."},{"key":"1183_CR2","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","volume":"17","author":"GBD 2016 Parkinson\u2019s Disease Collaborators.","year":"2018","unstructured":"GBD 2016 Parkinson\u2019s Disease Collaborators. Global, regional, and national burden of Parkinson\u2019s disease, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 17, 939\u2013953 (2018).","journal-title":"Lancet Neurol."},{"key":"1183_CR3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-080952","volume":"388","author":"D Su","year":"2025","unstructured":"Su, D. et al. Projections for prevalence of Parkinson\u2019s disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of Disease Study 2021. Br. Med. J. 388, e080952 (2025).","journal-title":"Br. Med. J."},{"key":"1183_CR4","first-page":"101046","volume":"44","author":"TH Schlickmann","year":"2025","unstructured":"Schlickmann, T. H. et al. Prevalence, distribution and future projections of Parkinson disease in Brazil: insights from the ELSI-Brazil cohort study. Lancet Reg. Health Am. 44, 101046 (2025).","journal-title":"Lancet Reg. Health Am."},{"key":"1183_CR5","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1001\/jamaneurol.2022.1783","volume":"79","author":"N Schiess","year":"2022","unstructured":"Schiess, N. et al. Six action steps to address global disparities in Parkinson disease: a World Health Organization priority. JAMA Neurol. 79, 929\u2013936 (2022).","journal-title":"JAMA Neurol."},{"key":"1183_CR6","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0140-6736(23)01419-8","volume":"403","author":"Y Ben-Shlomo","year":"2024","unstructured":"Ben-Shlomo, Y. et al. The epidemiology of Parkinson\u2019s disease. Lancet 403, 283\u2013292 (2024).","journal-title":"Lancet"},{"key":"1183_CR7","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41531-024-00779-y","volume":"10","author":"GM Pereira","year":"2024","unstructured":"Pereira, G. M. et al. A systematic review and meta-analysis of the prevalence of Parkinson\u2019s disease in lower to upper-middle-income countries. npj Parkinsons Dis. 10, 181 (2024).","journal-title":"npj Parkinsons Dis."},{"key":"1183_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.776847","volume":"9","author":"Z Ou","year":"2021","unstructured":"Ou, Z. et al. Global trends in the incidence, prevalence, and years lived with disability of Parkinson\u2019s disease in 204 countries\/territories from 1990 to 2019. Front. Public Health 9, 776847 (2021).","journal-title":"Front. Public Health"},{"key":"1183_CR9","doi-asserted-by":"publisher","first-page":"e464","DOI":"10.1016\/S2666-7568(24)00094-1","volume":"5","author":"J Zhu","year":"2024","unstructured":"Zhu, J. et al. Temporal trends in the prevalence of Parkinson\u2019s disease from 1980 to 2023: a systematic review and meta-analysis. Lancet Healthy Longev. 5, e464\u2013e479 (2024).","journal-title":"Lancet Healthy Longev."},{"key":"1183_CR10","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41531-025-00891-7","volume":"11","author":"S Siddiqi","year":"2025","unstructured":"Siddiqi, S. et al. Race and ethnicity matter! Moving Parkinson\u2019s risk research towards diversity and inclusiveness. npj Parkinsons Dis. 11, 45 (2025).","journal-title":"npj Parkinsons Dis."},{"key":"1183_CR11","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s41531-023-00523-y","volume":"9","author":"C Pearson","year":"2023","unstructured":"Pearson, C. et al. Care access and utilization among medicare beneficiaries living with Parkinson\u2019s disease. npj Parkinsons Dis. 9, 108 (2023).","journal-title":"npj Parkinsons Dis."},{"key":"1183_CR12","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1002\/mds.21153","volume":"21","author":"NU Okubadejo","year":"2006","unstructured":"Okubadejo, N. U., Bower, J. H., Rocca, W. A. & Maraganore, D. M. Parkinson\u2019s disease in Africa: a systematic review of epidemiologic and genetic studies. Mov. Disord. 21, 2150\u20132156 (2006).","journal-title":"Mov. Disord."},{"key":"1183_CR13","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1159\/000542606","volume":"59","author":"Q Yang","year":"2024","unstructured":"Yang, Q. et al. Disease burden of Parkinson\u2019s disease in Asia and its 34 countries and territories from 1990 to 2021: findings from the Global Burden of Disease Study 2021. Neuroepidemiology 59, 525\u2013557 (2024).","journal-title":"Neuroepidemiology"},{"key":"1183_CR14","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1159\/000275491","volume":"34","author":"A Wright Willis","year":"2010","unstructured":"Wright Willis, A., Evanoff, B. A., Lian, M., Criswell, S. R. & Racette, B. A. Geographic and ethnic variation in Parkinson disease: a population-based study of US Medicare beneficiaries. Neuroepidemiology 34, 143\u2013151 (2010).","journal-title":"Neuroepidemiology"},{"key":"1183_CR15","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1002\/mds.22557","volume":"24","author":"N Dahodwala","year":"2009","unstructured":"Dahodwala, N. et al. Racial differences in the diagnosis of Parkinson\u2019s disease. Mov. Disord. 24, 1200\u20131205 (2009).","journal-title":"Mov. Disord."},{"key":"1183_CR16","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41531-022-00410-y","volume":"8","author":"AW Willis","year":"2022","unstructured":"Willis, A. W. et al. Incidence of Parkinson disease in North America. npj Parkinsons Dis. 8, 170 (2022).","journal-title":"npj Parkinsons Dis."},{"key":"1183_CR17","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/s41531-023-00549-2","volume":"9","author":"S Harris","year":"2023","unstructured":"Harris, S., Narayanan, N. S. & Tranel, D. Does Black vs. White race affect practitioners\u2019 appraisal of Parkinson\u2019s disease? npj Parkinsons Dis. 9, 106 (2023).","journal-title":"npj Parkinsons Dis."},{"key":"1183_CR18","doi-asserted-by":"publisher","first-page":"512","DOI":"10.3389\/fneur.2020.00512","volume":"11","author":"MCJ Dekker","year":"2020","unstructured":"Dekker, M. C. J. et al. Parkinson\u2019s disease research on the African continent: obstacles and opportunities. Front. Neurol. 11, 512 (2020).","journal-title":"Front. Neurol."},{"key":"1183_CR19","doi-asserted-by":"publisher","first-page":"99","DOI":"10.62547\/SGFP1367","volume":"83","author":"E Ma","year":"2024","unstructured":"Ma, E., Krening, E., Seto, B. K. & Bruno, M. K. Challenges faced by rural health care providers caring for Parkinson\u2019s disease patients in neighbor islands of Hawai\u2019i. Hawaii J. Health Soc. Welf. 83, 99\u2013107 (2024).","journal-title":"Hawaii J. Health Soc. Welf."},{"key":"1183_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-019-1323-5","volume":"19","author":"Y Wan","year":"2019","unstructured":"Wan, Y. et al. Determinants of diagnostic latency in Chinese people with Parkinson\u2019s disease. BMC Neurol. 19, 120 (2019).","journal-title":"BMC Neurol."},{"key":"1183_CR21","doi-asserted-by":"publisher","first-page":"865","DOI":"10.3233\/JPD-150594","volume":"5","author":"AH Tan","year":"2015","unstructured":"Tan, A. H. et al. Knowledge of Parkinson\u2019s disease in a multiethnic urban Asian setting. J. Parkinsons Dis. 5, 865\u2013879 (2015).","journal-title":"J. Parkinsons Dis."},{"key":"1183_CR22","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.2105\/AJPH.2013.301706","volume":"104","author":"S George","year":"2014","unstructured":"George, S., Duran, N. & Norris, K. A systematic review of barriers and facilitators to minority research participation among African Americans, Latinos, Asian Americans, and Pacific Islanders. Am. J. Public Health 104, e16\u2013e31 (2014).","journal-title":"Am. J. Public Health"},{"key":"1183_CR23","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1001\/jamaneurol.2020.2412","volume":"77","author":"MJ Armstrong","year":"2020","unstructured":"Armstrong, M. J. & Okun, M. S. Time for a new image of Parkinson disease. JAMA Neurol. 77, 1345\u20131346 (2020).","journal-title":"JAMA Neurol."},{"key":"1183_CR24","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/mdc3.13584","volume":"10","author":"A Zirra","year":"2023","unstructured":"Zirra, A. et al. Gender differences in the prevalence of Parkinson\u2019s disease. Mov. Disord. Clin. Pract. 10, 86\u201393 (2023).","journal-title":"Mov. Disord. Clin. Pract."},{"key":"1183_CR25","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1186\/s12877-019-1332-7","volume":"19","author":"JH Park","year":"2019","unstructured":"Park, J. H. et al. Trends in the incidence and prevalence of Parkinson\u2019s disease in Korea: a nationwide, population-based study. BMC Geriatr. 19, 320 (2019).","journal-title":"BMC Geriatr."},{"key":"1183_CR26","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1159\/000065527","volume":"21","author":"H Kimura","year":"2002","unstructured":"Kimura, H. et al. Female preponderance of Parkinson\u2019s disease in Japan. Neuroepidemiology 21, 292\u2013296 (2002).","journal-title":"Neuroepidemiology"},{"key":"1183_CR27","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-026850","volume":"9","author":"M Kapoor","year":"2019","unstructured":"Kapoor, M. et al. Missing female patients: an observational analysis of sex ratio among outpatients in a referral tertiary care public hospital in India. BMJ Open 9, e026850 (2019).","journal-title":"BMJ Open"},{"key":"1183_CR28","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/mdc3.13903","volume":"11","author":"AH Tan","year":"2024","unstructured":"Tan, A. H. et al. Genetic testing for Parkinson\u2019s disease and movement disorders in less privileged areas: barriers and opportunities. Mov. Disord. Clin. Pract. 11, 14\u201320 (2024).","journal-title":"Mov. Disord. Clin. Pract."},{"key":"1183_CR29","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.parkreldis.2019.10.019","volume":"69","author":"DS Abraham","year":"2019","unstructured":"Abraham, D. S. et al. Sex differences in Parkinson\u2019s disease presentation and progression. Parkinsonism Relat. Disord. 69, 48\u201354 (2019).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1183_CR30","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1002\/mds.28921","volume":"37","author":"I Subramanian","year":"2022","unstructured":"Subramanian, I. et al. Unmet needs of women living with Parkinson\u2019s disease: gaps and controversies. Mov. Disord. 37, 444\u2013455 (2022).","journal-title":"Mov. Disord."},{"key":"1183_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.70354","author":"E Sarapura-Castro","year":"2025","unstructured":"Sarapura-Castro, E. et al. Prevalence of Parkinson\u2019s disease in a town of the Central Highlands of Peru: a population-based study. Mov. Disord. Clin. Pract. https:\/\/doi.org\/10.1002\/mdc3.70354 (2025).","journal-title":"Mov. Disord. Clin. Pract."},{"key":"1183_CR32","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/EDE.0000000000001717","volume":"35","author":"C Bonander","year":"2024","unstructured":"Bonander, C. et al. A capture\u2013recapture-based ascertainment probability weighting method for effect estimation with under-ascertained outcomes. Epidemiology 35, 340\u2013348 (2024).","journal-title":"Epidemiology"},{"key":"1183_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.70314","author":"\u00c1 Garc\u00eda-Bustillo","year":"2025","unstructured":"Garc\u00eda-Bustillo, \u00c1. et al. The feasibility and practical utility of virtual visits for patients with Parkinson\u2019s disease in different world regions. Mov. Disord. Clin. Pract. https:\/\/doi.org\/10.1002\/mdc3.70314 (2025).","journal-title":"Mov. Disord. Clin. Pract."},{"key":"1183_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0000583","volume":"2","author":"E Charani","year":"2022","unstructured":"Charani, E. et al. Funders: the missing link in equitable global health research? PLoS Glob. Public Health 2, e0000583 (2022).","journal-title":"PLoS Glob. Public Health"},{"key":"1183_CR35","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3233\/JPD-230357","volume":"14","author":"ER Dorsey","year":"2024","unstructured":"Dorsey, E. R. & Bloem, B. R. Parkinson\u2019s disease is predominantly an environmental disease. J. Parkinsons Dis. 14, 451\u2013465 (2024).","journal-title":"J. Parkinsons Dis."},{"key":"1183_CR36","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.foodpol.2012.06.003","volume":"37","author":"P Schreinemachers","year":"2012","unstructured":"Schreinemachers, P. & Tipraqsa, P. Agricultural pesticides and land use intensification in high, middle and low income countries. Food Policy 37, 616\u2013626 (2012).","journal-title":"Food Policy"},{"key":"1183_CR37","doi-asserted-by":"publisher","first-page":"12439","DOI":"10.1007\/s11356-020-07657-z","volume":"27","author":"HMA Siddique","year":"2020","unstructured":"Siddique, H. M. A. & Kiani, A. K. Industrial pollution and human health: evidence from middle-income countries. Environ. Sci. Pollut. Res. Int. 27, 12439\u201312448 (2020).","journal-title":"Environ. Sci. Pollut. Res. Int."},{"key":"1183_CR38","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1080\/19338244.2018.1492894","volume":"74","author":"W Tangamornsuksan","year":"2019","unstructured":"Tangamornsuksan, W. et al. Paraquat exposure and Parkinson\u2019s disease: a systematic review and meta-analysis. Arch. Environ. Occup. Health 74, 225\u2013238 (2019).","journal-title":"Arch. Environ. Occup. Health"},{"key":"1183_CR39","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.ijheh.2018.12.006","volume":"222","author":"MI Kasdagli","year":"2019","unstructured":"Kasdagli, M. I., Katsouyanni, K., Dimakopoulou, K. & Samoli, E. Air pollution and Parkinson\u2019s disease: a systematic review and meta-analysis up to 2018. Int. J. Hyg. Environ. Health 222, 402\u2013409 (2019).","journal-title":"Int. J. Hyg. Environ. Health"},{"key":"1183_CR40","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.taap.2012.11.016","volume":"266","author":"EA Lock","year":"2013","unstructured":"Lock, E. A., Zhang, J. & Checkoway, H. Solvents and Parkinson disease: a systematic review of toxicological and epidemiological evidence. Toxicol. Appl. Pharmacol. 266, 345\u2013355 (2013).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"1183_CR41","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1093\/aje\/kwad082","volume":"192","author":"Y Zhao","year":"2023","unstructured":"Zhao, Y., Ray, A., Portengen, L., Vermeulen, R. & Peters, S. Metal exposure and risk of Parkinson disease: a systematic review and meta-analysis. Am. J. Epidemiol. 192, 1207\u20131223 (2023).","journal-title":"Am. J. Epidemiol."},{"key":"1183_CR42","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.2421","volume":"1","author":"X Fang","year":"2018","unstructured":"Fang, X. et al. Association of levels of physical activity with risk of Parkinson disease: a systematic review and meta-analysis. JAMA Netw. Open 1, e182421 (2018).","journal-title":"JAMA Netw. Open"},{"key":"1183_CR43","doi-asserted-by":"publisher","first-page":"S221","DOI":"10.3233\/JAD-2010-091525","volume":"20","author":"J Costa","year":"2010","unstructured":"Costa, J., Lunet, N., Santos, C., Santos, J. & Vaz-Carneiro, A. Caffeine exposure and the risk of Parkinson\u2019s disease: a systematic review and meta-analysis of observational studies. J. Alzheimers Dis. 20 (Suppl. 1), S221\u2013S238 (2010).","journal-title":"J. Alzheimers Dis."},{"key":"1183_CR44","doi-asserted-by":"publisher","first-page":"3970","DOI":"10.3390\/nu13113970","volume":"13","author":"AJ Strikwerda","year":"2021","unstructured":"Strikwerda, A. J., Dommershuijsen, L. J., Ikram, M. K. & Voortman, T. Diet quality and risk of Parkinson\u2019s disease: the Rotterdam Study. Nutrients 13, 3970 (2021).","journal-title":"Nutrients"},{"key":"1183_CR45","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1002\/mds.25458","volume":"28","author":"S Jafari","year":"2013","unstructured":"Jafari, S., Etminan, M., Aminzadeh, F. & Samii, A. Head injury and risk of Parkinson disease: a systematic review and meta-analysis. Mov. Disord. 28, 1222\u20131229 (2013).","journal-title":"Mov. Disord."},{"key":"1183_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2023.105493","volume":"113","author":"DD Moura","year":"2023","unstructured":"Moura, D. D. et al. History of high household pesticide use and Parkinson\u2019s disease in Brazil. Parkinsonism Relat. Disord. 113, 105493 (2023).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1183_CR47","doi-asserted-by":"publisher","first-page":"1411468","DOI":"10.3389\/fneur.2024.1411468","volume":"15","author":"BL Santos-Lobato","year":"2024","unstructured":"Santos-Lobato, B. L. & Schuh, A. F. S. Exposure to household pesticides and Parkinson\u2019s disease in the Parkinson\u2019s Progression Markers Initiative cohort. Front. Neurol. 15, 1411468 (2024).","journal-title":"Front. Neurol."},{"key":"1183_CR48","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1001\/archneur.64.7.990","volume":"64","author":"B Ritz","year":"2007","unstructured":"Ritz, B. et al. Pooled analysis of tobacco use and risk of Parkinson disease. Arch. Neurol. 64, 990\u2013997 (2007).","journal-title":"Arch. Neurol."},{"key":"1183_CR49","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.envint.2013.03.004","volume":"56","author":"PC Lee","year":"2013","unstructured":"Lee, P. C., Rhodes, S. L., Sinsheimer, J. S., Bronstein, J. & Ritz, B. Functional paraoxonase 1 variants modify the risk of Parkinson\u2019s disease due to organophosphate exposure. Environ. Int. 56, 42\u201347 (2013).","journal-title":"Environ. Int."},{"key":"1183_CR50","doi-asserted-by":"publisher","first-page":"364","DOI":"10.4103\/neuroindia.NI_596_20","volume":"72","author":"B Kumar","year":"2024","unstructured":"Kumar, B. et al. Role of PON1 L55M gene polymorphism in Parkinson\u2019s disease among North Indian population. Neurol. India 72, 364\u2013367 (2024).","journal-title":"Neurol. India"},{"key":"1183_CR51","doi-asserted-by":"publisher","DOI":"10.1136\/bmjno-2022-000386","volume":"5","author":"F Najafi","year":"2023","unstructured":"Najafi, F. et al. Association between socioeconomic status and Parkinson\u2019s disease: findings from a large incident case-control study. BMJ Neurol. Open 5, e000386 (2023).","journal-title":"BMJ Neurol. Open"},{"key":"1183_CR52","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1002\/mds.30067","volume":"40","author":"K Atterling Brolin","year":"2025","unstructured":"Atterling Brolin, K. et al. Environmental risk factors for Parkinson\u2019s disease: a critical review and policy implications. Mov. Disord. 40, 204\u2013221 (2025).","journal-title":"Mov. Disord."},{"key":"1183_CR53","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/s41588-020-0580-y","volume":"52","author":"MC Mills","year":"2020","unstructured":"Mills, M. C. & Rahal, C. The GWAS Diversity Monitor tracks diversity by disease in real time. Nat. Genet. 52, 242\u2013243 (2020).","journal-title":"Nat. Genet."},{"key":"1183_CR54","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3390\/genes13030471","volume":"13","author":"F Jia","year":"2022","unstructured":"Jia, F., Fellner, A. & Kumar, K. R. Monogenic Parkinson\u2019s disease: genotype, phenotype, pathophysiology, and genetic testing. Genes 13, 471 (2022).","journal-title":"Genes"},{"key":"1183_CR55","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1002\/mds.29288","volume":"38","author":"EJ Vollstedt","year":"2023","unstructured":"Vollstedt, E. J. et al. Embracing monogenic Parkinson\u2019s disease: the MJFF Global Genetic PD Cohort. Mov. Disord. 38, 286\u2013303 (2023).","journal-title":"Mov. Disord."},{"key":"1183_CR56","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/mds.29614","volume":"39","author":"P Saffie Awad","year":"2024","unstructured":"Saffie Awad, P. et al. Frequency of hereditary and GBA1-related Parkinsonism in Latin America: a systematic review and meta-analysis. Mov. Disord. 39, 6\u201316 (2024).","journal-title":"Mov. Disord."},{"key":"1183_CR57","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fnagi.2019.00013","volume":"11","author":"L Shu","year":"2019","unstructured":"Shu, L., Zhang, Y., Sun, Q., Pan, H. & Tang, B. A comprehensive analysis of population differences in variant distribution in Parkinson\u2019s disease. Front. Aging Neurosci. 11, 13 (2019).","journal-title":"Front. Aging Neurosci."},{"key":"1183_CR58","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1002\/mds.29126","volume":"37","author":"AF Schumacher-Schuh","year":"2022","unstructured":"Schumacher-Schuh, A. F. et al. Underrepresented populations in Parkinson\u2019s genetics research: current landscape and future directions. Mov. Disord. 37, 1593\u20131604 (2022).","journal-title":"Mov. Disord."},{"key":"1183_CR59","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.3390\/genes14112097","volume":"14","author":"C Koros","year":"2023","unstructured":"Koros, C. et al. The landscape of monogenic Parkinson\u2019s disease in populations of non-European ancestry: a narrative review. Genes 14, 2097 (2023).","journal-title":"Genes"},{"key":"1183_CR60","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1002\/mds.29925","volume":"39","author":"J Junker","year":"2024","unstructured":"Junker, J. et al. Team science approaches to unravel monogenic Parkinson\u2019s disease on a global scale. Mov. Disord. 39, 1868\u20131873 (2024).","journal-title":"Mov. Disord."},{"key":"1183_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.648588","volume":"12","author":"D Guadagnolo","year":"2021","unstructured":"Guadagnolo, D., Piane, M., Torrisi, M. R., Pizzuti, A. & Petrucci, S. Genotype\u2013phenotype correlations in monogenic Parkinson disease: a review on clinical and molecular findings. Front. Neurol. 12, 648588 (2021).","journal-title":"Front. Neurol."},{"key":"1183_CR62","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1001\/jamaneurol.2020.0428","volume":"77","author":"JN Foo","year":"2020","unstructured":"Foo, J. N. et al. Identification of risk loci for Parkinson disease in Asians and comparison of risk between Asians and Europeans: a genome-wide association study. JAMA Neurol. 77, 746\u2013754 (2020).","journal-title":"JAMA Neurol."},{"key":"1183_CR63","doi-asserted-by":"publisher","unstructured":"Ak\u00e7imen, F. et al. Large-scale genetic characterization of Parkinson\u2019s disease in the African and African admixed populations. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2025.01.14.25320205 (2025).","DOI":"10.1101\/2025.01.14.25320205"},{"key":"1183_CR64","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/S1474-4422(24)00378-8","volume":"23","author":"SY Lim","year":"2024","unstructured":"Lim, S. Y. et al. Uncovering the genetic basis of Parkinson\u2019s disease globally: from discoveries to the clinic. Lancet Neurol. 23, 1267\u20131280 (2024).","journal-title":"Lancet Neurol."},{"key":"1183_CR65","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1002\/ana.26905","volume":"95","author":"M Khani","year":"2024","unstructured":"Khani, M. et al. Towards a global view of Parkinson\u2019s disease genetics. Ann. Neurol. 95, 831\u2013842 (2024).","journal-title":"Ann. Neurol."},{"key":"1183_CR66","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000200213","volume":"10","author":"AH Tan","year":"2024","unstructured":"Tan, A. H. et al. Global perspectives on returning genetic research results in Parkinson disease. Neurol. Genet. 10, e200213 (2024).","journal-title":"Neurol. Genet."},{"key":"1183_CR67","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","volume":"18","author":"MA Nalls","year":"2019","unstructured":"Nalls, M. A. et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies. Lancet Neurol. 18, 1091\u20131102 (2019).","journal-title":"Lancet Neurol."},{"key":"1183_CR68","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41531-024-00729-8","volume":"10","author":"MMX Tan","year":"2024","unstructured":"Tan, M. M. X. et al. Genome-wide determinants of mortality and motor progression in Parkinson\u2019s disease. npj Parkinsons Dis. 10, 113 (2024).","journal-title":"npj Parkinsons Dis."},{"key":"1183_CR69","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000200092","volume":"9","author":"A Mart\u00ednez Carrasco","year":"2023","unstructured":"Mart\u00ednez Carrasco, A. et al. Genome-wide analysis of motor progression in Parkinson disease. Neurol. Genet. 9, e200092 (2023).","journal-title":"Neurol. Genet."},{"key":"1183_CR70","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1002\/mds.28494","volume":"36","author":"Global Parkinson\u2019s Genetics Program.","year":"2021","unstructured":"Global Parkinson\u2019s Genetics Program. GP2: the Global Parkinson\u2019s Genetics Program. Mov. Disord. 36, 842\u2013851 (2021).","journal-title":"Mov. Disord."},{"key":"1183_CR71","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1002\/mds.27081","volume":"32","author":"CP Zabetian","year":"2017","unstructured":"Zabetian, C. P. & Mata, I. F. Latin American Research Consortium on the Genetics of PD (LARGE-PD). LARGE-PD: examining the genetics of Parkinson\u2019s disease in Latin America. Mov. Disord. 32, 1330\u20131331 (2017).","journal-title":"Mov. Disord."},{"key":"1183_CR72","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3233\/JPD-191854","volume":"10","author":"International Parkinson Disease Genomics Consortium (IPDGC).","year":"2020","unstructured":"International Parkinson Disease Genomics Consortium (IPDGC). Ten years of the International Parkinson Disease Genomics Consortium: progress and next steps. J. Parkinsons Dis. 10, 19\u201330 (2020).","journal-title":"J. Parkinsons Dis."},{"key":"1183_CR73","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/S1474-4422(21)00373-2","volume":"20","author":"KY Mok","year":"2021","unstructured":"Mok, K. Y. East Asian Parkinson Disease Genomics Consortium. The East Asian Parkinson Disease Genomics Consortium. Lancet Neurol. 20, 982 (2021).","journal-title":"Lancet Neurol."},{"key":"1183_CR74","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/ana.26153","volume":"90","author":"DP Loesch","year":"2021","unstructured":"Loesch, D. P. et al. Characterizing the genetic architecture of Parkinson\u2019s disease in Latinos. Ann. Neurol. 90, 353\u2013365 (2021).","journal-title":"Ann. Neurol."},{"key":"1183_CR75","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3389\/fneur.2020.00524","volume":"11","author":"R Rajan","year":"2020","unstructured":"Rajan, R. et al. Genetic architecture of Parkinson\u2019s disease in the Indian population: harnessing genetic diversity to address critical gaps in Parkinson\u2019s disease research. Front. Neurol. 11, 524 (2020).","journal-title":"Front. Neurol."},{"key":"1183_CR76","doi-asserted-by":"publisher","unstructured":"Step, K. et al. Genome-wide association analyses reveal susceptibility variants linked to Parkinson\u2019s disease in the South African population using inferred global and local ancestry. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2025.08.01.25331910 (2025).","DOI":"10.1101\/2025.08.01.25331910"},{"key":"1183_CR77","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41588-023-01584-8","volume":"56","author":"JJ Kim","year":"2024","unstructured":"Kim, J. J. et al. Multi-ancestry genome-wide association meta-analysis of Parkinson\u2019s disease. Nat. Genet. 56, 27\u201336 (2024).","journal-title":"Nat. Genet."},{"key":"1183_CR78","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/S1474-4422(23)00283-1","volume":"22","author":"M Rizig","year":"2023","unstructured":"Rizig, M. et al. Identification of genetic risk loci and causal insights associated with Parkinson\u2019s disease in African and African admixed populations: a genome-wide association study. Lancet Neurol. 22, 1015\u20131025 (2023).","journal-title":"Lancet Neurol."},{"key":"1183_CR79","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1038\/ng.487","volume":"41","author":"J Sim\u00f3n-S\u00e1nchez","year":"2009","unstructured":"Sim\u00f3n-S\u00e1nchez, J. et al. Genome-wide association study reveals genetic risk underlying Parkinson\u2019s disease. Nat. Genet. 41, 1308\u20131312 (2009).","journal-title":"Nat. Genet."},{"key":"1183_CR80","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41531-025-00967-4","volume":"11","author":"P Saffie-Awad","year":"2025","unstructured":"Saffie-Awad, P. et al. Insights into ancestral diversity in Parkinson\u2019s disease risk: a comparative assessment of polygenic risk scores. npj Parkinsons Dis. 11, 201 (2025).","journal-title":"npj Parkinsons Dis."},{"key":"1183_CR81","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41576-023-00637-2","volume":"25","author":"L Kachuri","year":"2024","unstructured":"Kachuri, L. et al. Principles and methods for transferring polygenic risk scores across global populations. Nat. Rev. Genet. 25, 8\u201325 (2024).","journal-title":"Nat. Rev. Genet."},{"key":"1183_CR82","doi-asserted-by":"publisher","first-page":"6168","DOI":"10.3390\/ijms25116168","volume":"25","author":"A Klokkaris","year":"2024","unstructured":"Klokkaris, A. & Migdalska-Richards, A. An overview of epigenetic changes in the Parkinson\u2019s disease brain. Int. J. Mol. Sci. 25, 6168 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"1183_CR83","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/s41593-024-01627-1","volume":"27","author":"S Lef\u00e8vre-Arbogast","year":"2024","unstructured":"Lef\u00e8vre-Arbogast, S. et al. Assessing the contribution of the chemical exposome to neurodegenerative disease. Nat. Neurosci. 27, 812\u2013821 (2024).","journal-title":"Nat. Neurosci."},{"key":"1183_CR84","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s41591-021-01672-4","volume":"28","author":"S Fatumo","year":"2022","unstructured":"Fatumo, S. et al. A roadmap to increase diversity in genomic studies. Nat. Med. 28, 243\u2013250 (2022).","journal-title":"Nat. Med."},{"key":"1183_CR85","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2022.0603","volume":"3","author":"TR Rebbeck","year":"2022","unstructured":"Rebbeck, T. R. et al. A framework for promoting diversity, equity, and inclusion in genetics and genomics research. JAMA Health Forum 3, e220603 (2022).","journal-title":"JAMA Health Forum"},{"key":"1183_CR86","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41525-024-00390-3","volume":"9","author":"C Bh\u00e9rer","year":"2024","unstructured":"Bh\u00e9rer, C. et al. A cost-effective sequencing method for genetic studies combining high-depth whole exome and low-depth whole genome. npj Genom. Med. 9, 8 (2024).","journal-title":"npj Genom. Med."},{"key":"1183_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.xgen.2023.100332","volume":"3","author":"D Sengupta","year":"2023","unstructured":"Sengupta, D. et al. Performance and accuracy evaluation of reference panels for genotype imputation in sub-Saharan African populations. Cell Genom. 3, 100332 (2023).","journal-title":"Cell Genom."},{"key":"1183_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-72653-z","volume":"14","author":"D Nicol","year":"2024","unstructured":"Nicol, D., Nielsen, J. & Archer, M. Data access arrangements in genomic research consortia. Sci. Rep. 14, 21685 (2024).","journal-title":"Sci. Rep."},{"key":"1183_CR89","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1016\/j.ajhg.2025.07.014","volume":"112","author":"C Blauwendraat","year":"2025","unstructured":"Blauwendraat, C. et al. Tackling a disease on a global scale, the Global Parkinson\u2019s Genetics Program, GP2: a new generation of opportunities. Am. J. Hum. Genet. 112, 1988\u20132000 (2025).","journal-title":"Am. J. Hum. Genet."},{"key":"1183_CR90","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3233\/JPD-171100","volume":"7","author":"S Heinzel","year":"2017","unstructured":"Heinzel, S., Lerche, S., Maetzler, W. & Berg, D. Global, yet incomplete overview of cohort studies in Parkinson\u2019s disease. J. Parkinsons Dis. 7, 423\u2013432 (2017).","journal-title":"J. Parkinsons Dis."},{"key":"1183_CR91","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1002\/acn3.644","volume":"5","author":"K Marek","year":"2018","unstructured":"Marek, K. et al. The Parkinson\u2019s progression markers initiative (PPMI) \u2014 establishing a PD biomarker cohort. Ann. Clin. Transl. Neurol. 5, 1460\u20131477 (2018).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"1183_CR92","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1002\/mds.26438","volume":"31","author":"LS Rosenthal","year":"2016","unstructured":"Rosenthal, L. S. et al. The NINDS Parkinson\u2019s disease biomarkers program. Mov. Disord. 31, 915\u2013923 (2016).","journal-title":"Mov. Disord."},{"key":"1183_CR93","doi-asserted-by":"publisher","first-page":"3395","DOI":"10.1111\/ene.15481","volume":"29","author":"D Pourzinal","year":"2022","unstructured":"Pourzinal, D. et al. Systematic review of data-driven cognitive subtypes in Parkinson disease. Eur. J. Neurol. 29, 3395\u20133417 (2022).","journal-title":"Eur. J. Neurol."},{"key":"1183_CR94","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3233\/JPD-202472","volume":"11","author":"TA Mestre","year":"2021","unstructured":"Mestre, T. A. et al. Parkinson\u2019s disease subtypes: critical appraisal and recommendations. J. Parkinsons Dis. 11, 395\u2013404 (2021).","journal-title":"J. Parkinsons Dis."},{"key":"1183_CR95","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41531-021-00185-8","volume":"7","author":"D Bega","year":"2021","unstructured":"Bega, D. et al. Clinical utility of DaTscan in patients with suspected Parkinsonian syndrome: a systematic review and meta-analysis. npj Parkinsons Dis. 7, 43 (2021).","journal-title":"npj Parkinsons Dis."},{"key":"1183_CR96","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S1474-4422(23)00109-6","volume":"22","author":"A Siderowf","year":"2023","unstructured":"Siderowf, A. et al. Assessment of heterogeneity among participants in the Parkinson\u2019s Progression Markers Initiative cohort using \u03b1-synuclein seed amplification: a cross-sectional study. Lancet Neurol. 22, 407\u2013417 (2023).","journal-title":"Lancet Neurol."},{"key":"1183_CR97","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41531-024-00768-1","volume":"10","author":"CC Pedersen","year":"2024","unstructured":"Pedersen, C. C. et al. Serum neurofilament light at diagnosis: a prognostic indicator for accelerated disease progression in Parkinson\u2019s disease. npj Parkinsons Dis. 10, 162 (2024).","journal-title":"npj Parkinsons Dis."},{"key":"1183_CR98","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s40035-024-00426-9","volume":"13","author":"H Mao","year":"2024","unstructured":"Mao, H. et al. Ultrasensitive detection of aggregated \u03b1-synuclein using quiescent seed amplification assay for the diagnosis of Parkinson\u2019s disease. Transl. Neurodegener. 13, 35 (2024).","journal-title":"Transl. Neurodegener."},{"key":"1183_CR99","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41531-024-00738-7","volume":"10","author":"Y Kuang","year":"2024","unstructured":"Kuang, Y. et al. A skin-specific \u03b1-synuclein seeding amplification assay for diagnosing Parkinson\u2019s disease. npj Parkinsons Dis. 10, 129 (2024).","journal-title":"npj Parkinsons Dis."},{"key":"1183_CR100","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1080\/14737175.2021.1886925","volume":"21","author":"CCG Alonso","year":"2021","unstructured":"Alonso, C. C. G., Silva, F. G., Costa, L. O. P. & Freitas, S. M. S. F. Smell tests to distinguish Parkinson\u2019s disease from other neurological disorders: a systematic review and meta-analysis. Expert Rev. Neurother. 21, 365\u2013379 (2021).","journal-title":"Expert Rev. Neurother."},{"key":"1183_CR101","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.smrv.2018.09.008","volume":"43","author":"A Galbiati","year":"2019","unstructured":"Galbiati, A., Verga, L., Giora, E., Zucconi, M. & Ferini-Strambi, L. The risk of neurodegeneration in REM sleep behavior disorder: a systematic review and meta-analysis of longitudinal studies. Sleep Med. Rev. 43, 37\u201346 (2019).","journal-title":"Sleep Med. Rev."},{"key":"1183_CR102","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s41531-024-00838-4","volume":"10","author":"JJ Kim","year":"2024","unstructured":"Kim, J. J. et al. Bidirectional relationship between olfaction and Parkinson\u2019s disease. npj Parkinsons Dis. 10, 232 (2024).","journal-title":"npj Parkinsons Dis."},{"key":"1183_CR103","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1212\/WNL.0b013e31825dd383","volume":"79","author":"RB Postuma","year":"2012","unstructured":"Postuma, R. B. et al. Environmental risk factors for REM sleep behavior disorder: a multicenter case-control study. Neurology 79, 428\u2013434 (2012).","journal-title":"Neurology"},{"key":"1183_CR104","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma, R. B. et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov. Disord. 30, 1591\u20131601 (2015).","journal-title":"Mov. Disord."},{"key":"1183_CR105","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/S1474-4422(23)00405-2","volume":"23","author":"T Simuni","year":"2024","unstructured":"Simuni, T. et al. A biological definition of neuronal \u03b1-synuclein disease: towards an integrated staging system for research. Lancet Neurol. 23, 178\u2013190 (2024).","journal-title":"Lancet Neurol."},{"key":"1183_CR106","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S1474-4422(23)00404-0","volume":"23","author":"GU H\u00f6glinger","year":"2024","unstructured":"H\u00f6glinger, G. U. et al. A biological classification of Parkinson\u2019s disease: the SynNeurGe research diagnostic criteria. Lancet Neurol. 23, 191\u2013204 (2024).","journal-title":"Lancet Neurol."},{"key":"1183_CR107","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1002\/mds.30007","volume":"39","author":"LV Kalia","year":"2024","unstructured":"Kalia, L. V. et al. International Parkinson and Movement Disorder Society viewpoint on biological frameworks of Parkinson\u2019s disease: current status and future directions. Mov. Disord. 39, 1710\u20131715 (2024).","journal-title":"Mov. Disord."},{"key":"1183_CR108","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s00702-023-02635-4","volume":"130","author":"U W\u00fcllner","year":"2023","unstructured":"W\u00fcllner, U. et al. The heterogeneity of Parkinson\u2019s disease. J. Neural Transm. 130, 827\u2013838 (2023).","journal-title":"J. Neural Transm."},{"key":"1183_CR109","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-7568(24)00132-6","volume":"5","author":"E McGlinchey","year":"2024","unstructured":"McGlinchey, E. et al. Biomarkers of neurodegeneration across the Global South. Lancet Healthy Longev. 5, 100616 (2024).","journal-title":"Lancet Healthy Longev."},{"key":"1183_CR110","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1002\/mds.29708","volume":"39","author":"C Marras","year":"2024","unstructured":"Marras, C. et al. Transitioning from subtyping to precision medicine in Parkinson\u2019s disease: a purpose-driven approach. Mov. Disord. 39, 462\u2013471 (2024).","journal-title":"Mov. Disord."},{"key":"1183_CR111","doi-asserted-by":"publisher","DOI":"10.3390\/cells14151161","author":"M Tanaka","year":"2025","unstructured":"Tanaka, M. Parkinson\u2019s disease: bridging gaps, building biomarkers, and reimagining clinical translation. Cells https:\/\/doi.org\/10.3390\/cells14151161 (2025).","journal-title":"Cells"},{"key":"1183_CR112","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-017-0985-0","volume":"17","author":"A Tanguy","year":"2017","unstructured":"Tanguy, A., J\u00f6nsson, L. & Ishihara, L. Inventory of real world data sources in Parkinson\u2019s disease. BMC Neurol. 17, 213 (2017).","journal-title":"BMC Neurol."},{"key":"1183_CR113","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000200226","volume":"11","author":"H Taylor","year":"2025","unstructured":"Taylor, H. et al. UK Biobank \u2014 a unique resource for discovery and translation research on genetics and neurologic disease. Neurol. Genet. 11, e200226 (2025).","journal-title":"Neurol. Genet."},{"key":"1183_CR114","doi-asserted-by":"publisher","unstructured":"Leal, T. P. et al. Genotype\u2013phenotype association study conducted on LARGE-PD reveals novel loci associated with Parkinson\u2019s disease. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2025.07.18.25331793 (2025).","DOI":"10.1101\/2025.07.18.25331793"},{"key":"1183_CR115","doi-asserted-by":"publisher","DOI":"10.1038\/s41597-024-03407-9","volume":"11","author":"J Gottesman","year":"2024","unstructured":"Gottesman, J. et al. Fox Insight at 5 years \u2014 a cohort of 54,000 participants contributing longitudinal patient-reported outcome, genetic, and microbiome data relating to Parkinson\u2019s disease. Sci. Data 11, 615 (2024).","journal-title":"Sci. Data"},{"key":"1183_CR116","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s12276-023-00952-y","volume":"55","author":"JH Oh","year":"2023","unstructured":"Oh, J. H. et al. Whole-genome sequencing reveals an association between small genomic deletions and an increased risk of developing Parkinson\u2019s disease. Exp. Mol. Med. 55, 555\u2013564 (2023).","journal-title":"Exp. Mol. Med."},{"key":"1183_CR117","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2025.1439325","volume":"13","author":"JJ Lv","year":"2025","unstructured":"Lv, J. J., Li, X. Y. & Yang, C. H. Urinary metal levels and their association with Parkinson\u2019s disease risk: insights from NHANES 2013\u20132020. Front. Public Health 13, 1439325 (2025).","journal-title":"Front. Public Health"},{"key":"1183_CR118","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.1045450","volume":"13","author":"M Alvarellos","year":"2022","unstructured":"Alvarellos, M. et al. Democratizing clinical-genomic data: how federated platforms can promote benefits sharing in genomics. Front. Genet. 13, 1045450 (2022).","journal-title":"Front. Genet."},{"key":"1183_CR119","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1212\/WNL.0000000000202757","volume":"100","author":"M Pandit","year":"2023","unstructured":"Pandit, M. et al. Prioritizing racial representation in treating people with Parkinson\u2019s disease: an assessment of racial inclusion among Parkinson\u2019s disease clinical trials between 1999\u20132022. Neurology 100, 2732 (2023).","journal-title":"Neurology"},{"key":"1183_CR120","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.parkreldis.2008.06.005","volume":"15","author":"MG Schneider","year":"2009","unstructured":"Schneider, M. G. et al. Minority enrollment in Parkinson\u2019s disease clinical trials. Parkinsonism Relat. Disord. 15, 258\u2013262 (2009).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1183_CR121","doi-asserted-by":"publisher","DOI":"10.1212\/CPJ.0000000000200113","volume":"13","author":"DG Di Luca","year":"2023","unstructured":"Di Luca, D. G. et al. Enrollment of participants from marginalized racial and ethnic groups: a comparative assessment of the STEADY-PD III and SURE-PD3 trials. Neurol. Clin. Pract. 13, e200113 (2023).","journal-title":"Neurol. Clin. Pract."},{"key":"1183_CR122","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1002\/mdc3.70009","volume":"12","author":"CC Tsai","year":"2025","unstructured":"Tsai, C. C. et al. Representational disparities in the enrollment of Parkinson\u2019s disease clinical trials. Mov. Disord. Clin. Pract. 12, 878\u2013881 (2025).","journal-title":"Mov. Disord. Clin. Pract."},{"key":"1183_CR123","doi-asserted-by":"publisher","first-page":"e608","DOI":"10.1016\/S2214-109X(25)00012-9","volume":"13","author":"V Moorthy","year":"2025","unstructured":"Moorthy, V. et al. Improving the clinical trial environment and infrastructure: moving from global resolution to action. Lancet Glob. Health 13, e608\u2013e610 (2025).","journal-title":"Lancet Glob. Health"},{"key":"1183_CR124","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1007\/s13311-020-00960-0","volume":"17","author":"PA Vaswani","year":"2020","unstructured":"Vaswani, P. A., Tropea, T. F. & Dahodwala, N. Overcoming barriers to Parkinson disease trial participation: increasing diversity and novel designs for recruitment and retention. Neurotherapeutics 17, 1724\u20131735 (2020).","journal-title":"Neurotherapeutics"},{"key":"1183_CR125","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.thorsurg.2021.09.012","volume":"32","author":"RM Hasson Charles","year":"2022","unstructured":"Hasson Charles, R. M., Sosa, E., Patel, M. & Erhunmwunsee, L. Health disparities in recruitment and enrollment in research. Thorac. Surg. Clin. 32, 75\u201382 (2022).","journal-title":"Thorac. Surg. Clin."},{"key":"1183_CR126","unstructured":"Fox Trial Finder. Parkinson\u2019s Disease. The Michael J. Fox Foundation for Parkinson\u2019s Research https:\/\/www.michaeljfox.org\/trial-finder (accessed 21 October 2025)."},{"key":"1183_CR127","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.bbr.2016.02.017","volume":"304","author":"J Gerstenberger","year":"2016","unstructured":"Gerstenberger, J., Bauer, A., Helmschrodt, C., Richter, A. & Richter, F. The novel adaptive rotating beam test unmasks sensorimotor impairments in a transgenic mouse model of Parkinson\u2019s disease. Behav. Brain Res. 304, 102\u2013110 (2016).","journal-title":"Behav. Brain Res."},{"key":"1183_CR128","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aas9292","author":"B Shutinoski","year":"2019","unstructured":"Shutinoski, B. et al. Lrrk2 alleles modulate inflammation during microbial infection of mice in a sex-dependent manner. Sci. Transl. Med. https:\/\/doi.org\/10.1126\/scitranslmed.aas9292 (2019).","journal-title":"Sci. Transl. Med."},{"key":"1183_CR129","doi-asserted-by":"publisher","first-page":"16577","DOI":"10.1073\/pnas.1900406116","volume":"116","author":"J Lee","year":"2019","unstructured":"Lee, J. et al. Sex-specific neuroprotection by inhibition of the Y-chromosome gene, in experimental Parkinson\u2019s disease. Proc. Natl Acad. Sci. USA 116, 16577\u201316582 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1183_CR130","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.nbd.2013.04.017","volume":"56","author":"C Hansen","year":"2013","unstructured":"Hansen, C. et al. A novel \u03b1-synuclein\u2013GFP mouse model displays progressive motor impairment, olfactory dysfunction and accumulation of \u03b1-synuclein\u2013GFP. Neurobiol. Dis. 56, 145\u2013155 (2013).","journal-title":"Neurobiol. Dis."},{"key":"1183_CR131","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.neurobiolaging.2021.01.010","volume":"101","author":"S Roshanbin","year":"2021","unstructured":"Roshanbin, S. et al. Age-related increase of alpha-synuclein oligomers is associated with motor disturbances in L61 transgenic mice. Neurobiol. Aging 101, 207\u2013220 (2021).","journal-title":"Neurobiol. Aging"},{"key":"1183_CR132","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/mds.28312","volume":"36","author":"H Iwaki","year":"2021","unstructured":"Iwaki, H. et al. Differences in the presentation and progression of Parkinson\u2019s disease by sex. Mov. Disord. 36, 106\u2013117 (2021).","journal-title":"Mov. Disord."},{"key":"1183_CR133","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.tig.2019.04.003","volume":"35","author":"MC Saul","year":"2019","unstructured":"Saul, M. C., Philip, V. M. & Reinholdt, L. G. Center for Systems Neurogenetics of Addiction & Chesler, E. J. High-diversity mouse populations for complex traits. Trends Genet. 35, 501\u2013514 (2019).","journal-title":"Trends Genet."},{"key":"1183_CR134","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/538161a","volume":"538","author":"AB Popejoy","year":"2016","unstructured":"Popejoy, A. B. & Fullerton, S. M. Genomics is failing on diversity. Nature 538, 161\u2013164 (2016).","journal-title":"Nature"},{"key":"1183_CR135","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34940-z","volume":"13","author":"S Ghosh","year":"2022","unstructured":"Ghosh, S., Nehme, R. & Barrett, L. E. Greater genetic diversity is needed in human pluripotent stem cell models. Nat. Commun. 13, 7301 (2022).","journal-title":"Nat. Commun."},{"key":"1183_CR136","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.gheart.2016.01.004","volume":"11","author":"GS Bloomfield","year":"2016","unstructured":"Bloomfield, G. S. et al. Training and capacity building in LMIC for research in heart and lung diseases: The NHLBI\u2013UnitedHealth Global Health Centers of Excellence program. Glob. Heart 11, 17\u201325 (2016).","journal-title":"Glob. Heart"},{"key":"1183_CR137","doi-asserted-by":"publisher","DOI":"10.1093\/function\/zqab060","volume":"2","author":"OH Petersen","year":"2021","unstructured":"Petersen, O. H. Inequality of research funding between different countries and regions is a serious problem for global science. Function 2, zqab060 (2021).","journal-title":"Function"},{"key":"1183_CR138","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1097\/WCO.0000000000001391","volume":"38","author":"GA Marconi","year":"2025","unstructured":"Marconi, G. A., Teixeira-Dos-Santos, D. & Schuh, A. F. S. Recent advances in the genetics of Parkinson\u2019s disease in underrepresented populations. Curr. Opin. Neurol. 38, 349\u2013354 (2025).","journal-title":"Curr. Opin. Neurol."},{"key":"1183_CR139","unstructured":"The Edmond J. Safra Fellowship in Movement Disorders. The Michael J. Fox Foundation https:\/\/www.michaeljfox.org\/edmond-j-safra-fellowship-movement-disorders (accessed 27 September 2025)."},{"key":"1183_CR140","doi-asserted-by":"publisher","first-page":"905","DOI":"10.3233\/JPD-212593","volume":"11","author":"B Siddiqi","year":"2021","unstructured":"Siddiqi, B. & Koemeter-Cox, A. A call to action: promoting diversity, equity, and inclusion in Parkinson\u2019s research and care. J. Parkinsons Dis. 11, 905\u2013908 (2021).","journal-title":"J. Parkinsons Dis."},{"key":"1183_CR141","unstructured":"Our commitment to diversity, equity & inclusion. Parkinson\u2019s Foundation https:\/\/www.parkinson.org\/about-us\/vision-mission\/diversity-equity-inclusion (accessed 27 September 2025)."},{"key":"1183_CR142","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2023.168913","volume":"912","author":"S Li","year":"2024","unstructured":"Li, S. et al. Cost-effectiveness analysis of insecticide ban aimed at preventing Parkinson\u2019s disease in central California. Sci. Total Environ. 912, 168913 (2024).","journal-title":"Sci. Total Environ."},{"key":"1183_CR143","unstructured":"Committee on Energy and Commerce. Dr. Emmanuel Bilirakis National Plan to End Parkinson\u2019s Act: Report (to accompany H.R. 2365) (United States Congress House, 2023)."},{"key":"1183_CR144","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2024.122914","volume":"458","author":"M Wasay","year":"2024","unstructured":"Wasay, M., Grisold, W., Wijeratne, T., Struhal, W. & Younis, S. World Federation of Neurology. The future of brain health advocacy: recommendations of the 2023 World Congress of Neurology advocacy panel. J. Neurol. Sci. 458, 122914 (2024).","journal-title":"J. Neurol. Sci."},{"key":"1183_CR145","unstructured":"Visiting trainee grants. International Parkinson and Movement Disorder Society https:\/\/www.movementdisorders.org\/MDS\/About\/MDS-Programs\/Visiting-Trainee-Grants.htm (accessed 12 October 2025)."},{"key":"1183_CR146","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-023-03414-0","volume":"23","author":"R Walker","year":"2023","unstructured":"Walker, R. et al. Transforming Parkinson\u2019s Care in Africa (TraPCAf): protocol for a multimethodology National Institute for Health and Care Research Global Health Research Group project. BMC Neurol. 23, 373 (2023).","journal-title":"BMC Neurol."},{"key":"1183_CR147","unstructured":"Fogarty Extramural Programs. Fogarty International Center https:\/\/www.fic.nih.gov\/Programs (accessed 12 October 2025)."},{"key":"1183_CR148","doi-asserted-by":"publisher","DOI":"10.1212\/CPJ.0000000000200138","volume":"13","author":"WW Aamodt","year":"2023","unstructured":"Aamodt, W. W., Willis, A. W. & Dahodwala, N. Racial and ethnic disparities in Parkinson disease: a call to action. Neurol. Clin. Pract. 13, e200138 (2023).","journal-title":"Neurol. Clin. Pract."},{"key":"1183_CR149","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1001\/jama.2021.13304","volume":"326","author":"A Flanagin","year":"2021","unstructured":"Flanagin, A., Frey, T. & Christiansen, S. L. AMA Manual of Style Committee. Updated guidance on the reporting of race and ethnicity in medical and science journals. JAMA 326, 621\u2013627 (2021).","journal-title":"JAMA"},{"key":"1183_CR150","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00415-025-13080-6","volume":"272","author":"J Lin","year":"2025","unstructured":"Lin, J. et al. Keeping an eye on Parkinson\u2019s disease: color vision and outer retinal thickness as simple and non-invasive biomarkers. J. Neurol. 272, 351 (2025).","journal-title":"J. Neurol."},{"key":"1183_CR151","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-16790-8","volume":"8","author":"QJ Yu","year":"2018","unstructured":"Yu, Q. J. et al. Parkinson disease with constipation: clinical features and relevant factors. Sci. Rep. 8, 567 (2018).","journal-title":"Sci. Rep."},{"key":"1183_CR152","doi-asserted-by":"publisher","first-page":"e138","DOI":"10.2500\/ajra.2015.29.4212","volume":"29","author":"A Altundag","year":"2015","unstructured":"Altundag, A. et al. Cross-culturally modified University of Pennsylvania Smell Identification Test for a Turkish population. Am. J. Rhinol. Allergy 29, e138\u2013e141 (2015).","journal-title":"Am. J. Rhinol. Allergy"},{"key":"1183_CR153","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12883-019-1340-4","volume":"19","author":"J Bu\u0161kov\u00e1","year":"2019","unstructured":"Bu\u0161kov\u00e1, J. et al. Validation of the REM sleep behavior disorder screening questionnaire in the Czech population. BMC Neurol. 19, 110 (2019).","journal-title":"BMC Neurol."},{"key":"1183_CR154","doi-asserted-by":"publisher","first-page":"8279","DOI":"10.1002\/alz.14242","volume":"20","author":"M Rivera Mindt","year":"2024","unstructured":"Rivera Mindt, M. et al. The Alzheimer\u2019s Disease Neuroimaging Initiative-4 (ADNI-4) Engagement Core: a culturally informed, community-engaged research (CI-CER) model to advance brain health equity. Alzheimers Dement. 20, 8279\u20138293 (2024).","journal-title":"Alzheimers Dement."},{"key":"1183_CR155","unstructured":"Parkinson\u2019s disease and related disorders. Accelerating Medicines Partnership https:\/\/amp-pd.org\/ (accessed 27 April 2025)."},{"key":"1183_CR156","volume":"2014","author":"L Horvat","year":"2014","unstructured":"Horvat, L., Horey, D., Romios, P. & Kis-Rigo, J. Cultural competence education for health professionals. Cochrane Database Syst. Rev. 2014, CD009405 (2014).","journal-title":"Cochrane Database Syst. Rev."},{"key":"1183_CR157","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0125466","volume":"10","author":"HG Skinner","year":"2015","unstructured":"Skinner, H. G. et al. Using community-based participatory research principles to develop more understandable recruitment and informed consent documents in genomic research. PLoS ONE 10, e0125466 (2015).","journal-title":"PLoS ONE"},{"key":"1183_CR158","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1353\/hpu.2021.0127","volume":"32","author":"T May","year":"2021","unstructured":"May, T. et al. Community-based participatory research and its potential role in supporting diversity in genomic science. J. Health Care Poor Underserved 32, 1208\u20131224 (2021).","journal-title":"J. Health Care Poor Underserved"},{"key":"1183_CR159","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-024-03914-7","volume":"24","author":"LM Chahine","year":"2024","unstructured":"Chahine, L. M. et al. The Black and African American Connections to Parkinson\u2019s Disease (BLAAC PD) study protocol. BMC Neurol. 24, 403 (2024).","journal-title":"BMC Neurol."},{"key":"1183_CR160","doi-asserted-by":"publisher","DOI":"10.1186\/s12961-020-00657-y","volume":"19","author":"L Woodland","year":"2021","unstructured":"Woodland, L., Blignault, I., O\u2019Callaghan, C. & Harris-Roxas, B. A framework for preferred practices in conducting culturally competent health research in a multicultural society. Health Res. Policy Syst. 19, 24 (2021).","journal-title":"Health Res. Policy Syst."},{"key":"1183_CR161","doi-asserted-by":"publisher","first-page":"809","DOI":"10.3233\/JPD-230444","volume":"14","author":"ML Zeissler","year":"2024","unstructured":"Zeissler, M. L. et al. Patient and public involvement and engagement in the development of a platform clinical trial for Parkinson\u2019s disease: an evaluation protocol. J. Parkinsons Dis. 14, 809\u2013821 (2024).","journal-title":"J. Parkinsons Dis."},{"key":"1183_CR162","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2022.106713","volume":"115","author":"AV Sanchez","year":"2022","unstructured":"Sanchez, A. V. et al. Designing the fostering inclusivity in research engagement for underrepresented populations in Parkinson\u2019s disease study. Contemp. Clin. Trials 115, 106713 (2022).","journal-title":"Contemp. Clin. Trials"},{"key":"1183_CR163","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-012332","volume":"7","author":"SRP Franzen","year":"2017","unstructured":"Franzen, S. R. P., Chandler, C. & Lang, T. Health research capacity development in low and middle income countries: reality or rhetoric? A systematic meta-narrative review of the qualitative literature. BMJ Open 7, e012332 (2017).","journal-title":"BMJ Open"},{"key":"1183_CR164","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S1474-4422(21)00100-9","volume":"20","author":"M Rizig","year":"2021","unstructured":"Rizig, M. et al. The International Parkinson Disease Genomics Consortium Africa. Lancet Neurol. 20, 335 (2021).","journal-title":"Lancet Neurol."},{"key":"1183_CR165","doi-asserted-by":"publisher","unstructured":"Kishore, A. et al. Deciphering the genetic architecture of Parkinson\u2019s disease in India. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2025.02.17.25322132 (2025).","DOI":"10.1101\/2025.02.17.25322132"},{"key":"1183_CR166","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/S1474-4422(24)00313-2","volume":"23","author":"R Central Asian and Transcaucasian Pa","year":"2024","unstructured":"Central Asian and Transcaucasian Parkinson\u2019s Disease Consortium & Kaiyrzhanov, R. A biobank for Parkinson\u2019s disease and atypical parkinsonism in central Asian and Transcaucasian regions. Lancet Neurol. 23, 859\u2013860 (2024).","journal-title":"Lancet Neurol."},{"key":"1183_CR167","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/S1474-4422(23)00453-2","volume":"23","author":"W Mohamed","year":"2024","unstructured":"Mohamed, W. et al. The AfrAbia+plus Parkinson\u2019s disease genomic consortium. Lancet Neurol. 23, 140\u2013141 (2024).","journal-title":"Lancet Neurol."},{"key":"1183_CR168","volume":"9","author":"MV Lourenco","year":"2023","unstructured":"Lourenco, M. V., Borelli, W. V., Duran-Aniotz, C., Zimmer, E. R. & de Castro, S. S. Promoting diversity and overcoming publication barriers in Latin American neuroscience and Alzheimer\u2019s disease research: a call to action. Alzheimers Dement. 9, e12378 (2023).","journal-title":"Alzheimers Dement."},{"key":"1183_CR169","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.parkreldis.2021.03.022","volume":"85","author":"JM Miyasaki","year":"2021","unstructured":"Miyasaki, J. M., Lim, T. T. & Bhidayasiri, R. Editorial: Inclusion, equity, diversity and social justice in movement disorders research. Parkinsonism Relat. Disord. 85, 114\u2013116 (2021).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1183_CR170","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-081123","volume":"389","author":"S Hopewell","year":"2025","unstructured":"Hopewell, S. et al. CONSORT 2025 statement: updated guideline for reporting randomised trials. Br. Med. J. 389, e081123 (2025).","journal-title":"Br. Med. J."},{"key":"1183_CR171","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-022-06138-5","volume":"15","author":"H Majid","year":"2022","unstructured":"Majid, H. et al. Publication dynamics: what can be done to eliminate barriers to publishing full manuscripts by the postgraduate trainees of a low-middle income country? BMC Res. Notes 15, 249 (2022).","journal-title":"BMC Res. Notes"},{"key":"1183_CR172","doi-asserted-by":"crossref","unstructured":"Diversity, equity and inclusion in neurology. Nat. Rev. Neurol. 20, 199 (2024).","DOI":"10.1038\/s41582-024-00951-1"},{"key":"1183_CR173","doi-asserted-by":"crossref","unstructured":"Amplifying under-represented perspectives. Nat. Commun. 13, 1834 (2022).","DOI":"10.1038\/s41467-022-29269-6"},{"key":"1183_CR174","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1161\/HYPERTENSIONAHA.123.20631","volume":"80","author":"AE Schutte","year":"2023","unstructured":"Schutte, A. E. & Abdool Karim, Q. Reimagining global hypertension research: from helicopter science to meaningful partnerships. Hypertension 80, 2239\u20132242 (2023).","journal-title":"Hypertension"},{"key":"1183_CR175","unstructured":"Montreal Statement. The World Conferences on Research Integrity Foundation https:\/\/www.wcrif.org\/guidance\/montreal-statement (accessed 3 May 2025)."},{"key":"1183_CR176","unstructured":"Global Code of Conduct https:\/\/dev.globalcodeofconduct.org\/ (accessed 3 May 2025)."},{"key":"1183_CR177","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/s41386-023-01534-2","volume":"48","author":"C Weinreb","year":"2023","unstructured":"Weinreb, C. & Sun, D. S. To dismantle structural racism in science, scientists need to learn how it works. Neuropsychopharmacology 48, 579\u2013582 (2023).","journal-title":"Neuropsychopharmacology"},{"key":"1183_CR178","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s41235-021-00349-3","volume":"6","author":"MR Banaji","year":"2021","unstructured":"Banaji, M. R., Fiske, S. T. & Massey, D. S. Systemic racism: individuals and interactions, institutions and society. Cogn. Res. Princ. Implic. 6, 82 (2021).","journal-title":"Cogn. Res. Princ. Implic."},{"key":"1183_CR179","doi-asserted-by":"publisher","unstructured":"Wonkam, A. et al. \u201cBlack Lives Matter and Black Research Matters\u201d: the African Society of Human Genetics\u2019 call to halt racism in science. Mol. Biol. Cell. https:\/\/doi.org\/10.1091\/mbc.E22-04-0122 (2022).","DOI":"10.1091\/mbc.E22-04-0122"},{"key":"1183_CR180","doi-asserted-by":"publisher","DOI":"10.1080\/23311886.2024.2443558","author":"BI Omodan","year":"2025","unstructured":"Omodan, B. I. Building reciprocal relationships through decolonial practices in academic research. Cogent Soc. Sci. https:\/\/doi.org\/10.1080\/23311886.2024.2443558 (2025).","journal-title":"Cogent Soc. Sci."},{"key":"1183_CR181","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2025.1578964","volume":"13","author":"A Adam","year":"2025","unstructured":"Adam, A. et al. Decolonizing global health research: experiences from the women in health and their economic, equity and livelihood statuses during emergency preparedness and response (WHEELER) study. Front. Public Health 13, 1578964 (2025).","journal-title":"Front. Public Health"}],"container-title":["Nature Reviews Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41582-026-01183-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41582-026-01183-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41582-026-01183-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T12:03:15Z","timestamp":1775131395000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41582-026-01183-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,10]]},"references-count":181,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["1183"],"URL":"https:\/\/doi.org\/10.1038\/s41582-026-01183-1","relation":{},"ISSN":["1759-4758","1759-4766"],"issn-type":[{"value":"1759-4758","type":"print"},{"value":"1759-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,10]]},"assertion":[{"value":"7 January 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}